Chronic ketamine use increases serum levels of brain-derived neurotrophic factor

Psychopharmacology

Volumn 215, Issue 1, 2011, Pages 143-148

  Ricci, Valerio ^a,b   Martinotti, Giovanni ^b   Gelfo, Francesca ^a   Tonioni, Federico ^b   Caltagirone, Carlo ^a,c   Bria, Pietro ^b   Angelucci, Francesco ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

BDNF; Drug abuse; Ketamine; Neurotoxicity; Neurotrophin; NGF; NMDA receptors; Serum levels

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; KETAMINE; NERVE GROWTH FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; MALE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 79955039215     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2121-3     Document Type: Article

References (55)

1. B Adams B Moghaddam 1998 Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine J Neurosci 18 5545 5554 9651235 1:CAS:528:DyaK1cXksFartLY%3D (Pubitemid 28311969)
2. CM Adler TE Goldberg AK Malhotra D Pickar A Breier 1998 Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers Biol Psychiatry 43 811 816 9611670 10.1016/S0006-3223(97)00556-8 1:CAS:528:DyaK1cXjsleqtLY%3D (Pubitemid 28288379)
3. F Angelucci SH Gruber A El Khoury PA Tonali AA Mathé 2007 Chronic amphetamine treatment reduces NGF and BDNF in the rat brain Eur Neuropsychopharmacol 17 756 762 17434716 10.1016/j.euroneuro.2007.03.002 1:CAS:528:DC%2BD2sXhtF2qt7bI (Pubitemid 47588860)
4. F Angelucci V Ricci M Pomponi G Conte AA Mathé P Tonali P Bria 2007 Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor J Psychopharmacol 21 820 825 17715210 10.1177/0269881107078491 1:CAS:528:DC%2BD1cXlsV2msA%3D%3D (Pubitemid 350029194)
5. F Angelucci V Ricci G Spalletta M Pomponi F Tonioni C Caltagirone P Bria 2008 Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers Eur Neuropsychopharmacol 18 882 887 18774699 10.1016/j.euroneuro.2008.07.008 1:CAS:528:DC%2BD1cXht1KmtLzN
6. F Angelucci V Ricci G Spalletta C Caltagirone AA Mathé P Bria 2009 Effects of psychostimulants on neurotrophins: implications for psychostimulant-induced neurotoxicity Int Rev Neurobiol 88 1 24 19897072 10.1016/S0074-7742(09)88001-X 1:CAS:528:DC%2BC3cXmt1Oguw%3D%3D
7. F Angelucci V Ricci G Martinotti I Palladino G Spalletta C Caltagirone P Bria 2010 Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from arise of drug-induced psychotic symptoms Addict Biol 15 3 365 367 20477754 10.1111/j.1369-1600.2010. 00221.x 1:CAS:528:DC%2BC3cXps1ags78%3D
8. NA Anis SC Berry NR Burton D Lodge 1983 The dissociative anaesthetics, ketamine and phencyclidine, selectively decrease excitation of central neurons by N-methyl-d-aspartate Br J Pharmacol 83 179 185
9. A Becker G Grecksch H Schwegler T Roskoden 2008 Expression of mRNA of neurotrophic factors and their receptors are significantly altered after subchronic ketamine treatment Med Chem 4 256 263 18473918 10.2174/ 157340608784325124 1:CAS:528:DC%2BD1cXmtFamtrc%3D (Pubitemid 351827300)
10. RM Berman A Cappiello A Anand DA Oren GR Heninger DS Charney JH Krystal 2000 Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 351 354 10686270 10.1016/S0006-3223(99)00230-9 1:CAS:528:DC%2BD3cXht1KqtrY%3D (Pubitemid 30109248)
11. LJ Bristow PH Hutson L Thorn MD Tricklebank 1993 The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents Br J Pharmacol 108 1156 1163 8485625 1:CAS:528:DyaK3sXisVOms7s%3D (Pubitemid 23102242)
12. E Carboni A Imperato L Perezzani G Di Chiara 1989 Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats Neuroscience 28 653 661 2710338 10.1016/0306-4522(89)90012-2 1:CAS:528:DyaL1MXhs1Kis7k%3D (Pubitemid 19081023)
13. B Connor M Dragunow 1998 The role of neuronal growth factors in neurodegenerative disorders of the human brain Brain Res Brain Res Rev 27 1 39 9639663 10.1016/S0165-0173(98)00004-6 1:CAS:528:DyaK1cXjvFOlurs%3D (Pubitemid 28300281)
14. HV Curran C Morgan 2000 Acute and residual effects of ketamine on recreational users: evidence for persisting cognitive impairments, dissociative and psychotic symptoms Addiction 95 575 590 10829333 10.1046/j.1360-0443.2000. 9545759.x 1:STN:280:DC%2BD3c3ovVWnsA%3D%3D
15. HV Curran C Morgan 2000 Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later Addiction 95 575 590 10829333 10.1046/j.1360-0443.2000.9545759.x 1:STN:280:DC%2BD3c3ovVWnsA%3D%3D (Pubitemid 30220252)
16. G De Foubert SL Carney CS Robinson EJ Destexhe R Tomlinson CA Hicks TK Murray JP Gaillard C Deville V Xhenseval CE Thomas MJ O'Neill TS Zetterström 2004 Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment Neuroscience 128 597 604 15381288 10.1016/j.neuroscience.2004.06.054 (Pubitemid 39277429)
17. GS De Oliveira KM Ceresér BS Fernandes M Kauer-Sant'Anna GR Fries L Stertz B Aguiar B Pfaffenseller F Kapczinski 2009 Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients J Psychiatr Res 43 1171 1174 19473667 10.1016/j.jpsychires.2009.04.002
18. ŁR Drzyzga A Marcinowska E Obuchowicz 2009 Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies Brain Res Bull 79 248 257 19480984 10.1016/j.brainresbull.2009.03.009 1:CAS:528:DC%2BD1MXms1Wmt7k%3D
19. First MB, Spietzer RL, Gibbon M, William JBW (1997) Structured clinical interview for DSM-1V axis 1 disorders clinical version. American Psychiatric, Washington
20. MF Folstein SE Folstein PR McHugh 1975 Mini-mental state. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189 198 1202204 10.1016/0022-3956(75)90026-6 1:STN:280: DyaE28%2FntFKjtw%3D%3D
21. LS Garcia CM Comim SS Valvassori GZ Réus LM Barbosa AC Andreazza L Stertz GR Fries EC Gavioli F Kapczinski J Quevedo 2008 Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus Prog Neuropsychopharmacol Biol Psychiatry 32 140 144 17884272 10.1016/j.pnpbp.2007.07.027 1:CAS:528: DC%2BD1cXptlWrug%3D%3D
22. MM Ghoneim JM Hinrichs SP Mewaldt RC Petersen 1985 Ketamine: behavioural effects of subanaesthetic doses J Clin Psychopharmacol 5 70 77 3988972 10.1097/00004714-198504000-00003 1:CAS:528:DyaL2MXktVSnu70%3D (Pubitemid 15149495)
23. DH Ha RT Robertson M Roshanaei JH Weiss 1999 Enhanced survival and morphological features of basal forebrain cholinergic neurons in vitro: role of neurotrophins and other potential cortically derived cholinergic trophic factors J Comp Neurol 406 156 170 10096603 10.1002/(SICI)1096-9861(19990405)406: 2<156::AID-CNE2>3.0.CO;2-K 1:CAS:528:DyaK1MXhvVKrsLY%3D (Pubitemid 29113831)
24. M Hamilton 1959 The assessment of anxiety states by rating Br J Med Psychol 32 50 55 13638508 1:STN:280:DyaG1M%2FmvVWisQ%3D%3D
25. M Hamilton 1960 A rating scale for depression J Neurol Neurosurg Psychiatry 23 56 62 14399272 10.1136/jnnp.23.1.56 1:STN:280:DyaF3c7ltFyksw%3D%3D
26. G Hansen SB Jensen L Chandresh T Hilden 1988 The psychotropic effect of ketamine J Psychoactive Drugs 20 419 425 3244062 1:STN:280:DyaL1M3hs1amug%3D%3D (Pubitemid 19047396)
27. GC Harborne FL Watson DT Healy L Groves 1996 The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers J Psychopharmacol 10 134 140 10.1177/026988119601000208 1:CAS:528:DyaK28XksVOks7o%3D (Pubitemid 26168448)
28. EW Harris AH Ganong CW Cotman 1984 Long term potentiation in the hippocampus involves activation of N-methyl-d-aspartate receptors Brain Res 323 132 137 6151863 10.1016/0006-8993(84)90275-0 1:CAS:528:DyaL2MXktVGitw%3D%3D (Pubitemid 15216780)
29. C Hyman M Hofer YA Barde M Juhasz GD Yancopoulos SP Squinto RM Lindsay 1991 BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 350 230 232 2005978 10.1038/350230a0 1:CAS:528:DyaK3MXhslyrtr8%3D (Pubitemid 21912205)
30. JC Ibla H Hayashi D Bajic SG Soriano 2009 Prolonged exposure to ketamine increases brain derived neurotrophic factor levels in developing rat brains Curr Drug Saf 4 11 16 19149520 10.2174/157488609787354495 1:CAS:528: DC%2BD1MXlt1Ggu74%3D
31. A Imperato MG Scrocco S Bacchi L Angelucci 1990 NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus Eur J Pharmacol 187 555 556 2150045 10.1016/0014-2999(90)90387-L 1:CAS:528:DyaK3MXnsFGmsA%3D%3D (Pubitemid 20357511)
32. M Irifune T Shimizu M Nomoto 1991 Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice Pharmacol Biochem Behav 40 399 407 1805243 10.1016/0091-3057(91)90571-I 1:CAS:528:DyaK38XhsFanug%3D%3D
33. M Irifune T Fukuda M Nomoto T Sato Y Kamata T Nishikawa W Mietani K Yokoyama K Sugiyama M Kawahara 1997 Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases Brain Res 763 281 284 9296573 10.1016/S0006-8993(97)00510-6 1:CAS:528:DyaK2sXksFanur8%3D (Pubitemid 27364452)
34. AJ Kastin W Pan LM Maness WA Banks 1999 Peptides crossing the blood-brain barrier: some unusual observations Brain Res 848 96 100 10612701 10.1016/S0006-8993(99)01961-7 1:CAS:528:DC%2BD3cXotVOr (Pubitemid 30001658)
35. DJ Kim S Roh Y Kim SJ Yoon HK Lee CS Han YK Kim 2005 High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users Neurosci Lett 388 112 115 16039058 10.1016/j.neulet.2005.06.042 1:CAS:528: DC%2BD2MXptVelt7g%3D (Pubitemid 41206742)
36. T Kos P Popik M Pietraszek D Schäfer W Danysz O Dravolina E Blokhina T Galankin AY Bespalov 2006 Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice Eur Neuropsychopharmacol 16 297 310 16288851 10.1016/j.euroneuro.2005.10.001 1:CAS:528:DC%2BD28Xjs1yhs7w%3D
37. JH Krystal LP Karper JP Seibyl GK Freeman R Delaney JD Bremner GR Heninger MB Bowers DS Charney 1994 Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 199 214 8122957 1:CAS:528:DyaK2cXkslemtrY%3D (Pubitemid 24081509)
38. SP Lad KE Neet EJ Mufson 2003 Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease Curr Drug Targets CNS Neurol Disord 2 315 334 14529363 10.2174/1568007033482724 1:CAS:528: DC%2BD3sXnvVyjt7s%3D
39. J Lee W Duan MP Mattson 2002 Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice J Neurochem 82 1367 1375 12354284 10.1046/j.1471-4159.2002.01085.x 1:CAS:528:DC%2BD38XnsV2hsro%3D
40. AK Malhotra DA Pinals H Weingartner K Sirocco CD Missar D Pickar A Breier 1996 NMDA receptor function and human cognition: the effects of ketamine in healthy subjects Neuropsychopharmacology 14 301 307 8703299 10.1016/0893- 133X(95)00137-3 1:CAS:528:DyaK28XivVGltbk%3D (Pubitemid 26151927)
41. AM Marini SJ Rabin RH Lipsky I Mocchetti 1998 Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate J Biol Chem 273 29394 29399 9792641 10.1074/jbc.273.45. 29394 1:CAS:528:DyaK1cXntlKqsbs%3D (Pubitemid 28509940)
42. GE Meredith S Callen DA Scheuer 2002 Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration Brain Res 949 218 227 12213320 10.1016/S0006-8993(02)03160-8 1:CAS:528:DC%2BD38Xms1yiu7g%3D (Pubitemid 35246197)
43. L Minichiello 2009 TrkB signalling pathways in LTP and learning Nat Rev Neurosci 10 850 860 19927149 10.1038/nrn2738 1:CAS:528:DC%2BD1MXhsVeqsbvF
44. B Moghaddam B Adams A Verma D Daly 1997 Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neurosci 17 2921 2927 9092613 1:CAS:528:DyaK2sXisValurk%3D (Pubitemid 27155025)
45. D Muller M Joly G Lynch 1988 Contributions of quisqualate and NMDA receptors to the induction and expression of long-term potentiation Science 242 1694 1697 2904701 10.1126/science.2904701 1:CAS:528:DyaL1MXmvFygsg%3D%3D (Pubitemid 19022175)
46. JW Newcomer NB Farber V Jevtovic-Todorovic G Selke AK Melson T Hershey S Craft JW Olney 1999 Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis Neuropsychopharmacology 20 106 118 9885791 10.1016/S0893-133X(98)00067-0 1:CAS:528:DyaK1MXjvFKmsw%3D%3D (Pubitemid 29010370)
47. M Nibuya EJ Nestler RS Duman 1996 Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J Neurosci 16 2365 2372 8601816 1:CAS:528:DyaK28XhvVCksrw%3D (Pubitemid 26154346)
48. W Pan WA Banks MB Fasold J Bluth AJ Kastin 1998 Transport of brain-derived neurotrophic factor across the blood-brain barrier Neuropharmacology 37 1553 1561 9886678 10.1016/S0028-3908(98)00141-5 1:CAS:528:DyaK1MXisFensQ%3D%3D (Pubitemid 28550429)
49. JS Silvestre R Nadal M Pallares N Ferré 1997 Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats Depress Anxiety 5 29 33 9250438 10.1002/(SICI)1520- 6394(1997)5:1<29::AID-DA5>3.0.CO;2-0 1:STN:280:DyaK2szpsVSitg%3D%3D (Pubitemid 28106010)
50. N Solowij W Hall N Lee 1992 Recreational MDMA use in Sydney: a profile of 'Ecstasy' users and their experience with the drug Br J Addict 87 1161 1172 1354992 10.1111/j.1360-0443.1992.tb02003.x 1:STN:280:DyaK38znvFCiug%3D%3D
51. H Thoenen 1995 Neurotrophins and neuronal plasticity Science 270 593 598 7570017 10.1126/science.270.5236.593 1:CAS:528:DyaK2MXovFGku7k%3D
52. C Verpelli G Piccoli A Zanchi F Gardoni K Huang D Brambilla M Di Luca E Battaglioli C Sala 2010 Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis J Neurosci 30 5830 5842 20427644 10.1523/JNEUROSCI.0119-10.2010 1:CAS:528:DC%2BC3cXosFeqsrc%3D
53. A Yilmaz D Schulz A Aksoy R Canbeyli 2002 Prolonged effect of an anesthetic dose of ketamine on behavioral despair Pharmacol Biochem Behav 71 341 344 11812542 10.1016/S0091-3057(01)00693-1 1:CAS:528:DC%2BD38Xms1KntQ%3D%3D (Pubitemid 34102497)
54. CA Zarate Jr JB Singh PJ Carlson NE Brutsche R Ameli DA Luckenbaugh DS Charney HK Manji 2006 A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 856 864 16894061 10.1001/archpsyc.63.8.856 1:CAS:528:DC%2BD28XovF2lsLo%3D (Pubitemid 44188478)
55. DX Zhang WB Levy 1992 Ketamine blocks the induction of LTP at the lateral entorhinal cortex-dentate gyrus synapses Brain Res 593 124 127 1458314 10.1016/0006-8993(92)91273-H 1:CAS:528:DyaK3sXlt1agug%3D%3D